UA87471C2 - Капсули, які містять пелети з діючими речовинами, які відрізняються між собою профілями вивільнення з них діючих речовин - Google Patents

Капсули, які містять пелети з діючими речовинами, які відрізняються між собою профілями вивільнення з них діючих речовин

Info

Publication number
UA87471C2
UA87471C2 UAA200603476A UAA200603476A UA87471C2 UA 87471 C2 UA87471 C2 UA 87471C2 UA A200603476 A UAA200603476 A UA A200603476A UA A200603476 A UAA200603476 A UA A200603476A UA 87471 C2 UA87471 C2 UA 87471C2
Authority
UA
Ukraine
Prior art keywords
different active
active substances
substances
differ
regard
Prior art date
Application number
UAA200603476A
Other languages
English (en)
Russian (ru)
Inventor
Сергей Аншютц
Роланд Шнайдер
Original Assignee
Фарматон С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фарматон С.А. filed Critical Фарматон С.А.
Publication of UA87471C2 publication Critical patent/UA87471C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Винахід стосується капсули, що містить пелети принаймні трьох груп з тим самим профілем вивільнення діючих речовин у кожній з них з діючими речовинами, які відрізняються між собою профілем вивільнення з них діючих речовин у шлунково-кишковому тракті й які містять принаймні дві різні діючі речовини, вибраних із групи вітамінів, мінеральних речовин, мікроелементів, ненасичених жирних кислот, амінокислот й/або рослинних екстрактів і речовин, при цьому вивільнення відповідних діючих речовин відбувається на всій ділянці всмоктування в шлунково-кишковому тракті (група І), у дванадцятипалій кишці або у дванадцятипалій кишці й у порожній кишці (група II), відповідно в порожній кишці, у порожній кишці й клубовій кишці або в клубовій кишці (група III).
UAA200603476A 2003-09-03 2004-08-28 Капсули, які містять пелети з діючими речовинами, які відрізняються між собою профілями вивільнення з них діючих речовин UA87471C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03019577 2003-09-03
PCT/EP2004/009617 WO2005023229A1 (de) 2003-09-03 2004-08-28 Kapsel enthaltend wirkstoffpellets mit unterschiedlichen freisetzungsprofilen

Publications (1)

Publication Number Publication Date
UA87471C2 true UA87471C2 (uk) 2009-07-27

Family

ID=34259144

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200603476A UA87471C2 (uk) 2003-09-03 2004-08-28 Капсули, які містять пелети з діючими речовинами, які відрізняються між собою профілями вивільнення з них діючих речовин

Country Status (17)

Country Link
US (1) US20050058704A1 (uk)
EP (1) EP1667665B1 (uk)
JP (1) JP4897483B2 (uk)
AT (1) ATE419841T1 (uk)
BR (1) BRPI0413201A (uk)
CA (1) CA2537477C (uk)
CY (1) CY1108950T1 (uk)
DE (1) DE502004008834D1 (uk)
DK (1) DK1667665T3 (uk)
ES (1) ES2317024T3 (uk)
MX (1) MXPA06002316A (uk)
PL (1) PL1667665T3 (uk)
PT (1) PT1667665E (uk)
RU (1) RU2356540C2 (uk)
SI (1) SI1667665T1 (uk)
UA (1) UA87471C2 (uk)
WO (1) WO2005023229A1 (uk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
CN1874764B (zh) * 2003-10-10 2012-08-01 埃法尔姆公司 含有银杏提取物的持续释放微粒及其制备方法
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
DE102006006532B4 (de) 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
JP5349290B2 (ja) * 2006-04-03 2013-11-20 オディディ，イサ 薬物送達組成物およびそれを含む医薬品、ならびにその製造方法
CN101674811B (zh) * 2007-02-09 2015-08-19 阿尔法制药有限公司 含有两种或更多种不同物理形态的活性药物成分的剂型
US20100255118A1 (en) * 2007-03-12 2010-10-07 Kanzer Steve H Oral zinc medicants useful for safely lowering free copper absorption and free copper levels
ES2841379T3 (es) 2007-03-13 2021-07-08 Jds Therapeutics Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2229155A4 (en) * 2007-12-12 2010-12-29 Northern Innovations And Formulations Corp PARTICLES IN A CAPSULE
CN102098921A (zh) 2008-05-19 2011-06-15 温顿制药有限公司 高载量、控释镁口服制剂及其制备和使用方法
US20110123609A1 (en) * 2008-07-19 2011-05-26 Sunil Shantwan Borude Multiple unit dosage form of niacin
US20130011469A1 (en) 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
CN102038691B (zh) * 2009-10-12 2014-06-11 杭州赛利药物研究所有限公司 一种维生素氨基酸的复合制剂及其制备方法
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
WO2014071176A1 (en) * 2012-11-02 2014-05-08 Disilvestro Robert Nutritional supplements including meal replacements and related methods
US20150104539A1 (en) * 2013-10-15 2015-04-16 Via Naturally, LLC Citrated folic acid compositions and methods for delivering folic acid to usp dissolution specifications
MX2018009748A (es) 2016-02-11 2019-02-07 Nutrition 21 Llc Composiciones que contienen cromo para mejorar la salud y el estado físico.
US20190201350A1 (en) * 2016-08-15 2019-07-04 Corr-Jensen Inc. Time release of fat-soluble actives
ES2695503B2 (es) * 2017-06-30 2020-05-08 Pharmalink S L Formulaciones encapsuladas
KR102368654B1 (ko) * 2020-04-17 2022-02-28 주식회사 청안오가닉스 녹차 카테킨을 포함하는 경구용 캡슐
CN111821266B (zh) * 2020-07-17 2021-09-14 迪沙药业集团有限公司 一种牛磺酸缓释组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50151874A (uk) * 1974-05-16 1975-12-06
JPS50151874U (uk) * 1974-06-01 1975-12-17
JPS5347513A (en) * 1976-10-14 1978-04-28 Meiji Seika Kaisha Ltd Preparation of enzymatic agent
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
JPS5982311A (ja) * 1982-11-04 1984-05-12 Shionogi & Co Ltd セフアレキシン持効性製剤
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
FR2705233B1 (fr) * 1993-05-14 1996-07-12 Atheliapharm Sa Nouvelles formes galéniques permettant la chronolibération différentielle d'associations de micronutriments utilisés en diététique et/ou thérapeutique.
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
IT1283478B1 (it) * 1996-07-22 1998-04-21 Roberto Valducci Composizioni per integrazione nutrizionale comprendenti vitamine idrosolubili a rilascio prolungato
AU5200098A (en) * 1996-11-01 1998-05-29 Ilex Oncology, Inc. Sustained release formulation containing dfmo
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
AU2697100A (en) * 1999-02-23 2000-09-14 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
WO2000069420A1 (en) * 1999-05-14 2000-11-23 Coraltis Ltd. Pulse-delivery oral compositions
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements

Also Published As

Publication number Publication date
BRPI0413201A (pt) 2006-10-03
WO2005023229A1 (de) 2005-03-17
ES2317024T3 (es) 2009-04-16
CA2537477A1 (en) 2005-03-17
PL1667665T3 (pl) 2009-06-30
RU2356540C2 (ru) 2009-05-27
JP2007504189A (ja) 2007-03-01
CY1108950T1 (el) 2014-07-02
EP1667665B1 (de) 2009-01-07
RU2006110549A (ru) 2007-10-10
DK1667665T3 (da) 2009-05-04
US20050058704A1 (en) 2005-03-17
PT1667665E (pt) 2009-02-13
JP4897483B2 (ja) 2012-03-14
CA2537477C (en) 2013-05-14
EP1667665A1 (de) 2006-06-14
MXPA06002316A (es) 2006-05-19
SI1667665T1 (sl) 2009-06-30
ATE419841T1 (de) 2009-01-15
DE502004008834D1 (de) 2009-02-26

Similar Documents

Publication Publication Date Title
UA87471C2 (uk) Капсули, які містять пелети з діючими речовинами, які відрізняються між собою профілями вивільнення з них діючих речовин
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
IL190646A (en) Multifunctional June Liquid Preparations, Including Pharmaceutical, Bioactive, Nutritional and Energetic Vehicles and Method for Preparing
EP2332522A3 (en) Biphasic controlled release delivery system for high solubility pharmaceuticals and method
HUP0004123A3 (en) Carboxylic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
IL168266A (en) Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments
IL156783A0 (en) Pharmaceutical composition for moulded capsules comprising eudragit 4135f, and process for its preparation
AU2003300833A8 (en) Solid compositions with improved bio-availability of insoluble or poorly water soluble drugs and a corresponding process for preparing such
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
WO2006058539A3 (en) Growth hormone secretagogue receptor 1a ligands
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
EP2292254A3 (en) Stabilized pharmaceutical peptide compositions
AU2003274681A8 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
WO2011149877A3 (en) Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods
MA26995A1 (fr) Derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
IL178425A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL174655A0 (en) Drug containing (2r)-2-propyloctanoic acid as the active ingredient
WO2005123034A8 (en) Microparticulate systems for the oral administration of biologically active substances
WO2006040779A3 (en) Controlled release gastric floating matrix formulation containing imatinib
HUP0300896A3 (en) Beta-amino acid nitrile derivatives, process for their preparation and pharmaceutical compositions containing them
IS6511A (is) Lyfjaefnablöndur sem innihalda sykurfitusýru estera til að stýra losun á virkum innihaldsefnum
SG116507A1 (en) Pharmaceutical dosage form and method of making.
SK500402007A3 (sk) Spôsob recyklácie odpadu z priemyselných výrob obsahujúceho zmes organických rozpúšťadiel a zariadenie na vykonávanie tohto spôsobu
SI1742927T1 (sl) Derivati butanojske kisline, postopki za pripravo le-teh, farmacevtski sestavki, ki jih vsebujejo in terapevtske uporabe le-teh
CA2556520A1 (en) Chromium-fatty acid compounds and methods of making and using thereof